Education
About Us
Working with TipRanks
Follow Us
Electrocore Llc (ECOR)
NASDAQ:ECOR
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.48Last Year’s EPS
-0.53Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 12, 2025
|% Change Since: -48.54%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, particularly in the VA channel and Truvaga sales, alongside improved financial metrics and strategic acquisitions. However, challenges were noted in the TAC-STIM product line, flat revenue in non-U.S. markets, and slower-than-expected progress in the Kaiser channel.Company Guidance
During the electroCore earnings call for the fiscal year 2024, CEO Dan Goldberger provided an extensive overview of the company's financial performance and strategic direction. The company reported a revenue of $25.2 million for the year, marking a 57% increase, with gross margins of 85%, up from 83% the previous year. electroCore's gammaCore products saw significant growth, particularly in the VA channel, which grew 85% year-over-year to $17.8 million. The Truvaga brand, launched in 2023, also showed robust performance with net sales reaching $2.8 million, a 174% increase over the prior year. The company narrowed its net loss by 37% and is making progress towards positive cash flow from operations. Goldberger highlighted the acquisition of NeuroMetrix, expected to close in Q2 2025, as a strategic move to enhance their bioelectronic health and wellness portfolio. He also noted the launch of Truvaga Plus on Amazon and the expansion into new distribution channels, aiming for sustained growth and leveraging established sales channels.Significant Revenue Growth
ElectroCore reported a revenue of $25.2 million for 2024, up 57% from the previous year, marking their ninth consecutive record revenue quarter with a 36% increase in Q4 over the prior year.
Strong Performance in VA Channel
Sales in the VA channel grew 85% to $17.8 million for the full year 2024, with Q4 sales increasing by 47% compared to the same quarter in 2023.
Truvaga Sales Surge
Truvaga net sales in 2024 were $2.8 million, representing a 174% increase over 2023, with a 271% increase in Q4 2024 compared to Q4 2023.
Improved Financial Metrics
Full year gross margins increased to 85% from 83% last year, and net loss narrowed by 37%.
Strategic Acquisitions
Acquisition of NeuroMetrix and a distribution agreement with Spark Biomedical aim to enhance the product portfolio in bioelectronic health and wellness.
---
ECOR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ECOR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 12, 2025 | $13.00 | $9.55 | -26.54% |
| Nov 13, 2024 | $13.40 | $13.60 | +1.49% |
| Aug 07, 2024 | $6.10 | $6.02 | -1.31% |
| May 08, 2024 | $7.24 | $6.85 | -5.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Electrocore Llc (ECOR) report earnings?
Electrocore Llc (ECOR) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Electrocore Llc (ECOR) earnings time?
Electrocore Llc (ECOR) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ECOR EPS forecast?
ECOR EPS forecast for the fiscal quarter 2025 (Q1) is -0.48.
---